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Preface From Editor
On behalf of the Editors, I am deeply grateful to all the reviewers who have been working
very hard for reviewing manuscripts submitted during the "3'd lnternational Conference on
Pharmacy and Advanced Pharmaceutical Sciences" held in Sheraton Hotel Yogyakarta, by the
Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, lndonesia on 18 - 19 June 2013.
We would like to acknowledge to keynote speakers and all the distinguished speakers for
their valuable contribution during this conference. Furthermore, we also thank the steering
committee for their advice and support. Finally, I would appreciate to all participants, paper and
poster presenters who participated in the conference as well as cordially contributed by
submitting their full manuscripts published in this proceeding.
Finally, we believe that the presence of this proceeding will significantly contribute to the
advance scientific research, especially in the field of Pharmaceutical Science and Thecnology.
Yogyakarta, June 2013,
Chief
Abdul Rohman
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Welcome to YogYakarta
Assalamu'alaikum wr wb
Honorable Rector of Universitas Gadjah Mada, Prof. Dr. Praktino, M'Soc'
Honorable our keynote speaker : dr. Boeniamin Setiawan, PhD
Honorable our distinguished invited speakers, our guests, and all participants
First of all, let us praise to the Almighty Allah SWT, because of His Blessing we are
able to attend this opening ceremony of the lnternational Conference on Pharmacy and
advanced pharmaceutical sciences today.
This morning, it is a great honor for me to welcome you all in this room in our conference'
Welcome to yogyakarta, and we hope you will enjoy your time here. This conference is the third
international conference conducted by Faculty of Pharmacy Universitas Gadjah Mada to
facilitate the experts meeting and sharing the knowldege among the researchers, academia,
college students, policy makers in corresponding fields, and practitioners.
This year, the theme of The 3'd lnternational Conference on Pharmacy and Advanced
pharmaceutical Sciences (ICPAPS 2013) is : "Pharmaceutical development towards a sustainable
and healthy society''. The conference is conducted in collaboration with Utrecht University the
Netherland, Nara lnstitute of Technology Japan, Mahidol University Thailand, and Cyberjaya
University, Malaysia. Thank you very much for our international partners.
As a key note speaker in this conference, we are fortunate to have dr. Boenjamin Setiawan, PhD'
He is the founder of Kalbe Farma, one of the big pharmaceutical company in lndonesia. His
experience in developing pharmaceutical company as a bussinessman as well as his vision in
development of medical and pharmaceutical research in lndonesia will be very inspiring, and
hopefully will guide us to develop research in our respective fields. We also invited 12 more
experts in various field of pharmacy and pharmaceutical sciences, either from lndonesia or
overseas, who will give their lectures.
Here, among 300 participants, there are 175 presenters from 10 countries will present their
recent research finding, which are divide into two big topics, Pharmaceutical Science and
Technology and Clinical and Social Pharmacy. Our high appreciation and sincere gratitude are
delivered to all speakers and presenters who enthusiastically participate in our conference.
The organizing commitee deeply acknowledges The Rector of Universitas Gadjah Mada, Nara
lnstitute of Technology Japan, Mahidol University Thailand, and Cyberjaya University, Malaysia'
as well as the sponsors for nice collaboration in conducting the conference. As the chairman of
the committee, I personally would like to express our high appreciation and gratitude to allteam
members for the hard work, dedication, and invaluable efforts for the success of the
conference.
Finally, we do hope that all participants could get benefit from this event and have enjoyable
moment in Yogyakarta.
Wassalamu'alaikum wr wb.
Chairman
Zullies lkawati
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Remark
Dean, Faculty of Pharmacy, Gadjah Mada University
Firstly, let's thanks to Allah who always blesses to all of us, so that we can get together in this
wonderful meeting, the 3'd lnternational Conference on Pharmacy and Advanced Pharmaceutical
Sciences (ICPAPS 2013). The Faculty of Pharmacy, Gadjah Mada University (GMU) is very happy
to welcome all of you ICPAPS 2013 participants in the meeting and also we welcome all of you in
Yogyakarta-lndonesia, the home of the Faculty of Pharmacy GMU.
Secondly, we'd like to give a brief introduction of our institution. Faculty of Pharmacy GMU was
erected in September L946, a year after lndonesian lndependence, is noted as the oldest Faculty
of Pharmacy in lndonesia. Faculty of Pharmacy GMU has been accredited nationally and
internationally as well. ln addition, collaboration in research, education, social services with
several National and overseas lnstitutions have been established, intended to achieve our goals,
one of those is qualityof education. Recently, new regulations on Pharmacist roles in lndonesia
have been emphasized as health profession, health promoter and pharmaceutical care.
Therefore, theme of this ICPAPS 2013 meeting is selected as 'Pharmaceutical developments
towards a sustainable and healthy society' that is parallel to those regulations. Faculty of
Pharmacy GMU really hopes that this meeting is fruitful for all participants in general and
specifically Pharmacy lnstitutions to develop to improve their education system.
Finally, Faculty of Pharmacy GMU highly appreciates to the Keynote speakers, invited speakers,
all participants for spending your time with us, the Committee ISteering Committee,
lnternational partners (Universiteit Utrecht-The Netherland, NAIST-Japan, Mahidol University-
Thailand, Cyberjaya University-Malaysia) Organizing Committeel who have been working very
hard, and last but not least Faculty of Pharmacy GMU thanks to our sponsors for this meeting.
Faculty of Pharmacy GMU realizes that without your participation, this meeting never happens.
Sincerely,
Subagus Wahyuono
ilr
The 3d Inlemational Conlerence on Pbanlacy And Adaanced Pbamacestical Sciences
Rector Speech
Rector, Universitas Gadjah Mada
It gives me genuine pleasure that Universitas Gadjah Mada has the honor of hosting the
lnternational Conference on Pharmacy and Advanced Pharmaceutical Sciences, which this year is
in its third installment. This Conference, held in collaboration with Japan's Nara lnstitute of
Sciences and Technology, the Netherlands' Universiteit Utrecht, Thailand's Mahidol University
and Malaysia's Cyberjaya University, reflects a global commitment maintained by members of
prominent think tanks the world over in addressing issues of common concern, which in this
year's ICPAPS are Advanced Pharmaceutical Science and Social and Clinical Pharmacy.
Universitas Gadjah Mada, as a leading institution of higher learning in lndonesia, and in its
commitment at becoming a World-Class Research University, has long since realized the spinal
role of global cooperation in achieving our visions. This is why we welcome any and all effort
through which international exchanges of thoughts and expertise can be encouraged. I see this
perspective reflected in its entirety in ICPAPS, wherein experts and thinkers from all around the
world will gather together and talk of a concerted effort to enhance the quality of pharmacists
worldwide, broaden the insights on pharmacy as well as pharmaceutical sciences and
technologies, and finally create both a national and international networking system for the
dissemination of developments in pharmaceutical sciences and technologies.
Since those are very noble causes we all need to not only address, but also eventually produce
into reality, I cannot impress the importance of this Conference for everyone present. Therefore,
I can only hope that all the participants, be they researchers, academicians, pharmacists in and
outside hospitals, as well as the students, are determined in making the best out of this brief
gathering.
I am looking forward to seeing rigorous debates, heated discussions and, most importantly, a
result that represents a joint international action held together by scientific truth. Thank you for
all your commitment and dedication in organizing and contributing to this conference, and I wish
you all the very best of luck.
Prof. Dr, Pratikno, M,Soc. Sc.
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PROCESS VALIDATION OF DICLOFENAC SODIUM PATCH MEMBRANE TYPE
WITH MENTHOL AS ENHANCER
Dewi Rashall*, Esti Hendradi*, Yuwono*
* Department of Pharmaceutics, Faculty of Pharmacy, Airlangga University (UNAIR), Surabaya,
60282, Indonesia
Co rres po nd i ng @ d ew i. ra shati @ya h oo. co m
ABSTRACT
The aim of this study was to prove that diclofenac sodium patch membrane
type with menthol as enhancer have fullfilled the acceptance criteria of process
validation. Methods: Diclofenac sodium patch membrane type was prepared by
mixing diclofenac sodium as active ingredient with additives such as alginate sodium
as drug reservoir, hydroxy propyl methyl cellulose as rate controlling membrane,
propilenglicol as plasticizer and menthol as enhancer. The evaluation included
organoleptics test, drug content of diclofenac sodium patch in first layer (drug-
reservoir), moisture content, homogenity test, drug content of diclofenac sodium
patch and drug release. Release of diclofenac sodium by dissolution test, which was
carried out using apparatus type S-paddle overdisk in phosphate buffer pH 7,4 (37
+ 0,50C, 50 rpm). The process validation was carried out for 3 days with 3 times
replication. Result: Fluks of diclofenac sodium release about 3,866 + 0,004. From
the overall results of test showed that CV <67o and one way ANOVA analysis
showed no significant difference of diclofenac sodium patchs were performed on 3
different days with 3 times replication. Conclusion: Process of manufacturing of
diclofenac sodium patch membrane type with menthol as enhancer has been
validated.
Key words: process validation, diclofenac sodium, patch, membrane type, menthol
INTRODUCTION
Inflammation is tissue vascularisation reaction because of injury. In general,
inflammation gives discomfort and are considered harmful to the patient (Singh et
a|.,2071). Diclofenac sodium is a NSAID drug that has anti-inflammatory, analgesic
and antipyretic effect and has high therapeutic index compared to other NSAID.
Diclofenac sodium is absorbed 100o/o after oral administration, but only 600/o of drug
that reaches systemic circulation due to first-pass metabolism. Additionally
diclofenac sodium have gastric irritation effect on oral route (Chuasuwan et al,
2008). To avoid this problems, the transdermal route can be alternative option for
this drug. One of the dosage form of transdermal is patch. Patch is a dosage form
that designed to deliver drug through the skin. In membrane systems, patch has a
separate drug layer in solution, suspension, gel form or dispersed in the matrix
polymer between backing layer and rate controlling membrane that can produce
zero-order release rate (Bajaj et al,2OlL). In this research, I choose membrane
type patch because it can provide better rate control of delivery and has initial burst
in drug release (Margetts and Sawyer,2007).
In a previous study, in vitro test of patch showed well drug release (Pujianti,
2006). Significant changes to the process that can affect the quality of the product
have to be validated (BPOM, 2006). Therefore, it is necessary to ensure that the
validation process for manufacturing of sodiurn diclofenac patch will consistently
produce a product that conforms to predetermined specifications.
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METHODOLOGY
Instrument
The instrument used in this research include analytical balance, Scanning
Electron Microscope (sEM), UV visible Spectrophotometer , oven, magnetic stirei,
SCHOTT GLAS mainz pH meter CG 842 type, series of instrument foi penetrationpercutan testing ERWEIG DT 700, cell diffusion, desiccator and glass.
Material
The main materials used in this research is pharmaceutical grade. These
materials include diclofenac sodium (Aarti Drugs Limited), sodium alginate (Sigma-
Aldrich), HPMC E15 (ILE pharmaceutical), propylene gtycol (Bratacliem), meithol(Bratachem), ethanol 96% (Bratachem) and distilled water.
Manufacturing Patch
1. Manufacture of drug reservoir patch
0,1 g Diclofenac sodium dissolved with 11 mL mixture of water: ethanol80:20 using stirrer 500 rpm for 5 minutes, then add 5,232 g sodium alginate 9yo
and stirring constantly with a stirrer 500 rpm for 10 minutes. The resulting mixtureis divided into 3 dosage of each patch and weighed 3,967 g then porrja on thebacking membrane. Mixed drug-reservoir is then dried at tem--perature at 45" C fort hour to form a semi-dry matrix. Patch then tested drug content of diclofenac
sodium in first layer (mixture drug- reseruoir).
2. Manufacture of rate controlling membrane
5,L2 g HPMC Et5 2oo/o was added 0.213 g propylene glycol and stirring
constantly using a stirrer 500 rpm for 10 minutes.0,106 g l'lenthol dissolved ii
ethanol and added to the mixture, stirring constantly with J stirrer 500 rpm for 5
min. The mixture was then poured on drug reservoir and dried at temperature of 40o C for 2 hours. Patches then tested organoleptic, surface homogeneity assay,
homogeneity of dosage form, moisture content, drug content and rel6ase di-ug. rde
validation process is carried out for 3 days, each with 3 times replic-ation.
Formulation of diclofenac sodium patch with menthol as enhancer can be seen in
table 1.
Table 1 lation of diclofe um n
Material
Formu
Diklofenac sodium l4
inat sodium 9olo
HPMC E15 200lo 720
Menthol 5
Total 1515
Statistical analysis
Drug content in first layer (drug-reservoir), moisture content, drug contentin the patch and drug release of diclofenac sodium in validation process are
analyzed using program SPSS (Statistical Package for the Social Sciences) t7 by
one-way analysis of variance (ANOVA).
RESULTS AND DISCUSSION
Validation process is intended to provide assurance that the preparationprocess will consistently produce a product according to predetermined
specifications (Nash and Wachter, 2003). Before performed validation process,
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7m
30
Function YtEtuttL ltttu,Control
Bahan aktif l4
Drug reservoir 736
Rate-controlling
membrane
720
Plastisizer 30
Enhancer
1500
7
ilenolicol
1
facilities, systems and equipment used must have been qualified and analytical
methods must be validated (BPOM, 2006).
Maximum Wavelength and standard curve result
The maximum wavelength (l) of diclofenac sodium was 276 nm at
absorbance 0,450. Standard curve can be seen in this table. From data analysis
obtained regression equation for standard curve was y = 0.032 x - 0.007 with a
correlation coefficient (r) = 0.99997. This is indicates that there is a linear
relationship between absorption and diclofenac sodium levels so can be used as a
curve standard.
Drug content in first layer
Drug content in first layer of sodium diclofenac patch membrane type with
menthol as enhancer can be seen in table 2. Content of sodium diclofenac were in
the range 98-702o/o and CV on each day <60/o. Based on one-way ANOVA test found
that there was no significant difference (p = 0,347) content of sodium diclofenac
membran type patch in manufacturing 3 different days with each of three
replication.
Organoleptic Assay
Organoleptic assay's result of diclofenac sodium patch membrane type with
menthol as enhancer is a patch has a round shape, thin and smooth surface;
translucent brownish color and smelling menthol. Based on the results of
organoleptic test was found that there was no difference organoleptic in the
manufacture of sodium diclofenac patch on 3 different days.
Surface homogeneity assay
Result of surface homogeneity sodium diclofenac patch using a Scanning
Electron Microscope (SEM) with a magnification of 1000 x can be seen in picture 1.
This picture indicating that the addition of menthol resulted in visible suface patch
elicits a uniform distribution on the surface of diclofenac sodium patch.
Picture 1. Surface homogeneity of diclofenac sodium patch using Scanning Electron
Microscope (SEM) with a magniflcation of 1000 x. A: Patch diclofenac
sodium type membranes without menthol B: Patch diclofenac
sodium with menthol as enhancer.
Moisture Content Assay
The results of the percentage average moisture content diclofenac sodium
patch can be seen in table 2. The percentage of moisture content obtained were in
the range 10-15%. Percentage CV obtained on each day of <60lo. Based on one-way
ANOVA test found that there was no significant difference (p = 0,586) percentage of
A
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Table 2. Assay of Validation process
CV olo
Drug content in
first layer
0 31
19
0
2 6B
Moisture Content 2 78
4 79
0 2
Drug Content 0 34
0 50
0 10
Fluks of release 10
0 13
Drug Content
Drug content of diclofenac sodium patch were in the range 98-tO2o/o and CV
obtained on each day of <6%o. Based on one-way ANOVA test found that there was
no significant difference (p = 0,278) content of diclofenac sodium membran typepatch in manufacturing 3 different days with each of three replication.
Drug Release
Data cumulative amount and profil of diclofenac sodium patch release canbe seen in table 3 and picture 2. Data is cumulative amount of diclofenac sodiumpatch with 3 times the replication * 5p. p;sp1 data of release, is make linear
regression equation between time (minutes) versus the cumulative amount ofdiclofenac sodium (pg / cm') were released from the minute 0-480. Flux value is the
slope of the regression equation.
Table 3 Cumulative amount of Diclofenac sodium
replication
patch release with 3 times
Data is cumulative amount of diclofenac sodium patch 3 times the replication +
SD
Dav o/o Auerage * SD
I 99,28 + 0,30
II ggpz+ 0,19
III 98 88 + 0,39
I 72,28 * O,33
II 11,94+ 0,33
III L2,27* 0,59
I 98,89 + 0,29
II 98,50 + 0,33
III 99,06 + 0,50
I 31866 + 0,004
II 3,862 + 0,004III 3,865 + 9,995
Waktu Hari I Hari II Hari III KV (o/o)
0 0,000 * 0,000 0,000 * 0.000 q,Q00 + 0,000 0,00
15 553,211 + 11,211 532,42t * 9,675 538,342 + 6.814 1,98
30 896,281 + 4,683 815,805 + 20,653 847,806 + 10,255 4,7s
45 1053,884 t 4,772 1052,156 * 7,995 1 990+ 5 1,63
60 1284,346 * 4,044 1254,360 + 8,153 1260,964 + 7,994 t,24
90 t7o3,622 r 2t,262 1546,21,2 r 11,483 1539,493 * L7,048 5,82
120 1840,728 L L.429 1981,376 t 32,729 1840,014 + 13.730 4,31
180 2t61,932 + 2,637 2t82,829 * 24.832 2210,302 + t4,257 1,1 1
240 2289,892 * 2,663 2288,708 *. t9,227 2288,955 * 12,784 0,03
300 2376,545 + 2.689 2375,360 + 8.895 2371,898 + 5,088 0,10
360 2416,262 + 6,649 2405,412 * 0,885 2436,L20 L 4.391 0,64
420 2498,528 t 7,220 2451,Lst * 8,397 2461,354 * 6,196 1,01
480 2574,698 * 2,728 2519,425 + 9.486 2501,480 + L4,332 1,51
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Picture 2. Profil of diclofenac sodium patch release
Drug release is performed to determine the amount of drug released from
the base. At delivery patch, the drug is in high concentration.. Because of the high
concentration in the patch and the presence of low concentrations in the blood, then
drug will diffuse continuously to maintain a constant concentration of drug in the
circulation (Bajaj et al, 2011). Process of drug transport through barrier constituted
by Fick's first law, namely the number of molecules of compounds that pass through
each unit barrier in each unit of time expressed as a fluks (J) (Martin, 1993)
Percentage CV of fluks sodium diclofenac were obtained on each day of
<6%o. Based on one-way ANOVA test found that there was no significant difference(p = O.+6t ) fluks of diclofenac sodium patch release by making the patch on 3
different days with each of the three replication.
Homogeneity of dosage form
Preparation homogenity test of sodium diclofenac, patch is divided into 4
sections. The results of homogeneity test of diclofenac sodium patch membrane
type with menthol enhancer can be seen in table 4. Based on one-way ANOVA test
found that there was no significant difference (p = 0.777) content of diclofenac
sodium patch membrane type with menthol as enhancer by making the patch on 3
different days with each of the three replication. Percentage CV obtained on each
day of <60lo so it can show that the content of diclofenac sodium patch membrane
type has been spread homogeneous in surface of patch.
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Table 4. Results of homogeneity test of diclofenac sodium patch membrane type
with menthol enhancer
Dav Replication Average drug content (o/o) *SD CV (o/o)
I 1 99,86 * 0,73 0,73
2 99,31 + 0,84 0,84
3 99,45 + 0,86 0,87
II 1 99,L6 L 0,73 0,73
2 99,28 + l,Lz 1,13
3 99,45 + 1,54 1,55III 1 99,64 + 1,13 1,13
2 99,53 * 0,72 O,7L
3 99,38 * 1,12 L,t2
From the overall results of test showed that cv <6yo and one way ANovA
analysis showed no significant difference of diclofenac sodium patchs were
performed on 3 different days with 3 times replication.
Conclusion
The process of manufacture of sodium diclofenac patch membrane type with
menthol as enhancer has been validated
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